US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 6, 2018 (8 years ago)

Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.

What was recalled

Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11

Recalling firm
Par Pharmaceutical, Inc.
NDC code
10370-252-11
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1185-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all